Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the safety and efficacy of cotadutide in participants with non-cirrhotic NASH with fibrosis.


Clinical Trial Description

A Phase 2, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of two different doses of cotadutide at 300 and 600 μg in participants with non-cirrhotic non-alcoholic steatohepatitis with fibrosis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05364931
Study type Interventional
Source AstraZeneca
Contact
Status Completed
Phase Phase 2
Start date July 14, 2022
Completion date April 19, 2024